Variants of unknown significance on chromosomal microarray analysis: parental perspectives
Chromosomal microarray is the recommended first-tier genetic test when a child presents with idiopathic developmental delay (DD), intellectual disability (ID), and/or autism spectrum disorder (ASD). Microarray may discover variants of unknown clinical significance (VUS) and been suggested to cause parental stress and anxiety. A retrospective, mixed methods study investigated parental perceptions of chromosomal microarray results that contain VUS. Surveys were sent to parents of children with DD/ID/ASD following a VUS result to seek information regarding parental understanding of the result, perceived value, and perceptions of child vulnerability and parental stress. Parents reported that chromosomal microarray was important for understanding their child’s diagnosis and they were satisfied with the information. A majority of parents reported high confidence in their ability to explain a VUS result to others. Of the parents who reported they received support, many reported that the support was from a genetic counselor. Based on these results, VUS results are important to parents of children with DD/ID/ASD and genetic counseling regarding VUS results contributes positively to both parental understanding and support.
KeywordsChromosomal microarray analysis Variant of unknown significance Autism spectrum disorder Developmental delay Intellectual disability
- National Human Genome Research Institute (NHGRI) (2004) Design considerations for a potential United States population-based cohort to determine the relationships among genes, environment, and health: Recommendations of an expert panel. www.genome.gov/pages/about/OD/ReportsPublications/PotentialUSCohort.pdf
- Aatre RD, Day SM (2011) Psychological issues in genetic testing for inherited cardiovascular diseases. J Am Heart Assoc 4:81–90Google Scholar
- Abidin RR (1995) Parenting stress index (PSI), 3rd edn. Psychologocal Assessment Resources, OdessaGoogle Scholar
- Bell J, Sistermans E, Ramsden SC (2008) Practice guidelines for the interpretation and reporting of unclassified variants (UVs) in clinical molecular genetics. Clin Mol Genet Soc 1–6Google Scholar
- Miles MB, Huberman AM (1994) Qualitative data analysis. Sage, Thousand OaksGoogle Scholar